Nuvalent (NUVL) Interest Coverage Ratio (2020 - 2026)
Nuvalent (NUVL) posted Interest Coverage Ratio of 0.26 for Q1 2026, down 19.53% on a QoQ basis from 0.21 in Q4 2025, and up 9.57% year-over-year from 0.23 in Q1 2025.
Nuvalent (NUVL) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
Nuvalent's Interest Coverage Ratio history runs 7 years deep, the most recent figure standing at 0.26 for Q1 2026.
- Quarterly Interest Coverage Ratio rose 9.57% year-over-year to 0.26 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.94 (up 2.31% YoY) and the FY2025 annual result came in at 0.87, down 23.59% from the prior year.
- Interest Coverage Ratio was 0.26 for Q1 2026 at Nuvalent, down from 0.21 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 0.1 in Q4 2023 and bottomed at 59.0 in Q1 2023.
- A 5-year average of 13.51 and a median of 0.29 in 2025 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2022 — Interest Coverage Ratio tumbled 2833.23% — and 2024, when it surged 99.58%.
- Nuvalent's Interest Coverage Ratio stood at 21.78 in 2022, then surged by 99.53% to 0.1 in 2023, then slumped by 109.63% to 0.22 in 2024, then rose by 0.93% to 0.21 in 2025, then retreated by 19.53% to 0.26 in 2026.
- Business Quant data shows NUVL's Interest Coverage Ratio at 0.26 in Q1 2026, 0.21 in Q4 2025, and 0.26 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Nuvalent | 9.75 Bn | 9.75 Bn | - | -0.26 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.26 |
| Dec 31, 2025 | -0.21 |
| Sep 30, 2025 | -0.26 |
| Jun 30, 2025 | -0.29 |
| Mar 31, 2025 | -0.28 |
| Dec 31, 2024 | -0.22 |
| Sep 30, 2024 | -0.12 |
| Jun 30, 2024 | -0.15 |
| Mar 31, 2024 | -37.91 |
| Dec 31, 2023 | -0.10 |
| Sep 30, 2023 | -29.61 |
| Jun 30, 2023 | -22.16 |
| Mar 31, 2023 | -59.00 |
| Dec 31, 2022 | -21.78 |
| Sep 30, 2022 | -23.52 |
| Jun 30, 2022 | -16.53 |
| Mar 31, 2022 | -17.31 |
| Dec 31, 2021 | -0.74 |
| Dec 31, 2020 | -0.53 |